{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:00:49Z","timestamp":1788267649238,"version":"build-2803163510"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007824","name":"Soochow University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background\/objectives<\/jats:title>\n                    <jats:p>As an increasing number of emerging economies move beyond a simple recipient role in global vaccine partnerships, their engagement with Gavi has become more diverse and institutionally layered. This study examined how different participation pathways in Gavi were associated with domestic immunization strengthening and roles in global vaccine procurement, using China and India as two comparable emerging economies with contrasting modes of engagement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A long-term qualitative comparative case study was conducted for 2000\u20132025 using a most-similar systems design. The analysis combined process tracing and structured cross-case comparison. Evidence was triangulated from institutional documents and public databases, Gavi and WHO materials, corporate disclosures and partnership records, peer-reviewed studies, and semi-structured interviews conducted between 2019 and 2025. The materials were manually coded around role evolution, participation mechanisms, pathway orientation, and outcome mapping.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Two distinct participation pathways were identified. China followed a state-coordinated pathway in which Gavi-related engagement was linked more closely to domestic system development, policy alignment, and selective donor-oriented repositioning. Corporate participation was limited and episodic, with the most visible expansion occurring during the COVID-19 period under government coordination. India followed a market-integrated pathway, characterized by sustained manufacturer participation in UNICEF\u2013Gavi pooled procurement. This pathway was supported by WHO-prequalified products, technology-transfer arrangements, large-scale production, and cost competitiveness. The comparison suggests that China\u2019s engagement was more closely associated with domestic system consolidation, whereas India\u2019s engagement was associated with a stronger position in global vaccine supply but coexisted with more uneven domestic immunization-system outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Emerging economies do not engage with Gavi through a single pathway, and these differences have important public health implications. For major Southern vaccine-producing countries, public health policy may need to better sequence global engagement with domestic system strengthening: first improving delivery, cold-chain, workforce, surveillance, and information systems; then upgrading regulatory capacity and WHO prequalification readiness; and finally linking industrial upgrading and procurement participation to equitable vaccine access.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1826364","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:19:40Z","timestamp":1779949180000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Participation pathways in global vaccine partnerships and their implications for immunization systems: a comparative analysis of China and India in Gavi"],"prefix":"10.3389","volume":"14","author":[{"given":"Mengli","family":"Ding","sequence":"first","affiliation":[{"name":"School of Politics and Public Administration, Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1987502","DOI":"10.1080\/17441692.2021.1987502","article-title":"COVAX and the rise of the \u2018super public private partnership\u2019 for global health","volume":"18","author":"Storeng","year":"2023","journal-title":"Glob Public Health"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.socscimed.2006.09.001","article-title":"Seven habits of highly effective global public-private health partnerships: practice and potential","volume":"64","author":"Buse","year":"2007","journal-title":"Soc Sci Med"},{"key":"ref3","year":"2023"},{"key":"ref4","year":"2026"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"709127","DOI":"10.3389\/fpubh.2021.709127","article-title":"COVID-19 vaccination in lower-middle income countries: national stakeholder views on challenges, barriers, and potential solutions","volume":"9","author":"Tagoe","year":"2021","journal-title":"Front Public Health"},{"key":"ref6","year":"2020"},{"key":"ref7","year":"2024"},{"key":"ref8","year":"2021"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2307\/1955513","article-title":"Comparative politics and the comparative method","volume":"65","author":"Lijphart","year":"1971","journal-title":"Am Polit Sci Rev"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1744-8603-9-15","article-title":"\u2018BRICS without straw\u2019? A systematic literature review of newly emerging economies\u2019 influence in global health","volume":"9","author":"Harmer","year":"2013","journal-title":"Glob Health"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1017\/s0260210514000345","article-title":"The rise of companies from emerging markets in global health governance: opportunities and challenges","volume":"40","author":"Roemer-Mahler","year":"2014","journal-title":"Rev Int Stud"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.3390\/healthcare10071276","article-title":"China\u2019s vaccine diplomacy and its implications for global health governance","volume":"10","author":"Liu","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.34172\/hpp.2023.34","article-title":"The rise of India\u2019s global health diplomacy amid COVID-19 pandemic","volume":"13","author":"Chattu","year":"2023","journal-title":"Health Promot Perspect"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/09692290.2022.2074514","article-title":"Political economy of vaccine diplomacy: explaining varying strategies of China, India, and Russia\u2019s COVID-19 vaccine diplomacy","volume":"30","author":"Suzuki","year":"2023","journal-title":"Rev Int Polit Econ"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e012","DOI":"10.1590\/0034-7329202200222","article-title":"BRICS and global health diplomacy in the COVID-19 pandemic","volume":"65","author":"Moore","year":"2022","journal-title":"Rev Bras Polit Int"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"J15","DOI":"10.1016\/j.vaccine.2013.03.045","article-title":"The inception, achievements, and implications of the China GAVI Alliance project on hepatitis B immunization","volume":"31","author":"Kane","year":"2013","journal-title":"Vaccine"},{"key":"ref17","year":""},{"key":"ref18","year":"2016"},{"key":"ref19","year":"2015"},{"key":"ref20","year":"2021"},{"key":"ref21","year":"2021"},{"key":"ref22","year":"2022"},{"key":"ref23","author":"Baker","year":"2023"},{"key":"ref24","year":"2023"},{"key":"ref25","year":"2016"},{"key":"ref26","year":""},{"key":"ref27","volume-title":"The Potential impact of Proposed Gavi Funding Cuts on Global Health Security","author":"Ramakrishnan","year":"2025"},{"key":"ref28","year":""},{"key":"ref29","year":"2025"},{"key":"ref30","year":""},{"key":"ref31","volume-title":"Science Diplomacy Case Studies","author":"Ghosh","year":"2019"},{"key":"ref32","year":"2020"},{"key":"ref33","year":"2021"},{"key":"ref34","year":"2025"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"7883","DOI":"10.1016\/j.vaccine.2020.10.056","article-title":"India\u2019s cost-effective COVID-19 vaccine development initiatives","volume":"38","author":"Chakraborty","year":"2020","journal-title":"Vaccine"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2020529","DOI":"10.1080\/21645515.2021.2020529","article-title":"Capacity building for vaccine manufacturing across developing countries: the way forward","volume":"18","author":"Kumraj","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"ref37","year":"2020"},{"key":"ref38","author":"Siddiqui","year":"2025"},{"key":"ref39","year":""},{"key":"ref40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1257\/pandp.20201017","article-title":"Advance market commitments: insights from theory and experience","volume":"110","author":"Kremer","year":"2020","journal-title":"AEA Pap Proc"},{"key":"ref41","year":"2013"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"J73","DOI":"10.1016\/j.vaccine.2012.09.060","article-title":"Key outcomes and addressing remaining challenges\u2014perspectives from a final evaluation of the China GAVI project","volume":"31","author":"Yang","year":"2013","journal-title":"Vaccine"},{"key":"ref43","first-page":"441","article-title":"Progress in hepatitis B prevention through universal infant vaccination\u2014China, 1997\u20132006","volume":"56","author":"Cui","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref44","year":"2026"},{"key":"ref45","year":"2020"},{"key":"ref46","year":"2024"},{"key":"ref47","first-page":"S57","article-title":"Role of global Alliance for vaccines and immunization (GAVI) in accelerating inactivated polio vaccine introduction","volume":"53","author":"Thacker","year":"2016","journal-title":"Indian Pediatr"},{"key":"ref48","year":""},{"key":"ref49","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1377\/hlthaff.2015.1079","article-title":"Gavi\u2019s transition policy: moving from development assistance to domestic financing of immunization programs","volume":"35","author":"Kallenberg","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"ref50","year":"2024"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(21)01052-7","article-title":"India\u2019s COVID-19 emergency","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"ref52","year":"2020"},{"key":"ref53","year":"2026"},{"key":"ref54","year":"2026"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1826364\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:19:44Z","timestamp":1779949184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1826364\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":54,"alternative-id":["10.3389\/fpubh.2026.1826364"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1826364","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"article-number":"1826364"}}